Literature DB >> 26711234

PURE mRNA display for in vitro selection of single-chain antibodies.

Yu Nagumo1, Kei Fujiwara1, Kenichi Horisawa1, Hiroshi Yanagawa1, Nobuhide Doi2.   

Abstract

mRNA display is a method to form a covalent linkage between a cell-free synthesized protein (phenotype) and its encoding mRNA (genotype) through puromycin for in vitro selection of proteins. Although a wheat germ cell-free translation system has been previously used in our mRNA display system, a protein synthesis using recombinant elements (PURE) system is a more attractive approach because it contains no endogenous nucleases and proteases and is optimized for folding of antibodies with disulphide bonds. However, when we used the PURE system for mRNA display of single-chain Fv (scFv) antibodies, the formation efficiency of the mRNA-protein conjugates was quite low. To establish an efficient platform for the PURE mRNA display of scFv, we performed affinity selection of a library of scFv antibodies with a C-terminal random sequence and obtained C-terminal sequences that increased the formation of mRNA-protein conjugates. We also identified unexpected common substitution mutations around the start codon of scFv antibodies, which were inferred to destabilize the mRNA secondary structure. This destabilization causes an increase in protein expression and the efficiency of the formation of mRNA-protein conjugates. We believe these improvements should make the PURE mRNA display more efficient for selecting antibodies for diagnostic and therapeutic applications.
© The Authors 2015. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  PURE system; antibody engineering; cell-free translation; puromycin; ribosome stalling

Mesh:

Substances:

Year:  2015        PMID: 26711234     DOI: 10.1093/jb/mvv131

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  4 in total

Review 1.  Directing evolution of novel ligands by mRNA display.

Authors:  Golnaz Kamalinia; Brian J Grindel; Terry T Takahashi; Steven W Millward; Richard W Roberts
Journal:  Chem Soc Rev       Date:  2021-06-24       Impact factor: 60.615

2.  Enhanced mRNA-protein fusion efficiency of a single-domain antibody by selection of mRNA display with additional random sequences in the terminal translated regions.

Authors:  Kazuki Takahashi; Masato Sunohara; Takuya Terai; Shigefumi Kumachi; Naoto Nemoto
Journal:  Biophys Physicobiol       Date:  2017-02-11

Review 3.  The science of puromycin: From studies of ribosome function to applications in biotechnology.

Authors:  Ranen Aviner
Journal:  Comput Struct Biotechnol J       Date:  2020-04-24       Impact factor: 7.271

Review 4.  Cyclic Peptides: Promising Scaffolds for Biopharmaceuticals.

Authors:  Donghyeok Gang; Do Wook Kim; Hee-Sung Park
Journal:  Genes (Basel)       Date:  2018-11-16       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.